Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile
Jason Tucker-Schwartz, PhD

@jtuckerschwartz

Medtech leadership, strategy, marketing, bus dev | Engineer by training via UVa, Vanderbilt, and MIT | Unhealthy obsession with soccer

ID: 1063579066920517633

calendar_today16-11-2018 23:46:24

296 Tweet

256 Followers

650 Following

Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

What an exciting day for our team! This has been three+ years of really hard work. I’m grateful to be able to work with such a talented and engaging group of founders, board members, clinical advisers, and of course the entire team at SpectraWAVE!

Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

It's getting really exciting around here! Such a privilege to have someone like Dr. Ali on the podium discussing SpectraWAVE. Can't wait for what's to come!

SpectraWAVE (@spectrawave_med) 's Twitter Profile Photo

We’re excited to head out to Phoenix, AZ for #SCAI2023 next week! Come by Booth 204 to learn more about the future of intravascular imaging with the HyperVue Imaging System!

We’re excited to head out to Phoenix, AZ for #SCAI2023 next week! Come by Booth 204 to learn more about the future of intravascular imaging with the HyperVue Imaging System!
SpectraWAVE (@spectrawave_med) 's Twitter Profile Photo

Thank you to Ryan Madder for sharing about DeepOCT + NIRS during his presentation on Invasive Plaque Characterization at #SCAI2023. To learn more about our next gen intravascular imaging platform head to our website spectrawave.com!

Thank you to <a href="/RyanMadderMD/">Ryan Madder</a> for sharing about DeepOCT + NIRS during his presentation on Invasive Plaque Characterization at #SCAI2023. To learn more about our next gen intravascular imaging platform head to our website spectrawave.com!
Chuck Simonton (@drchucksimonton) 's Twitter Profile Photo

Fantastic to see Spectrawave at SCAI! The ease of use features, DeepOCT images with superior depth of field, amazing resolution and ultrafast pullback speeds allowing saline flush, and NIRS lipid detection, make this a truly innovative entry into imaging. Eman Namati Gregg W. Stone MD

SpectraWAVE (@spectrawave_med) 's Twitter Profile Photo

Thanks to OPCI for the opportunity for CEO Eman Namati to present the HyperVue Imaging System to an amazing room of physicians, industry professionals, and hospital administrators! Visit SpectraWAVE.com to see more about what SpectraWAVE has built. #OPCI2023

Thanks to <a href="/OPCILive/">OPCI</a> for the opportunity for CEO <a href="/EmanNamati/">Eman Namati</a> to present the HyperVue Imaging System to an amazing room of physicians, industry professionals, and hospital administrators! 
Visit SpectraWAVE.com to see more about what <a href="/SpectraWAVE_Med/">SpectraWAVE</a> has built. 
#OPCI2023
SpectraWAVE (@spectrawave_med) 's Twitter Profile Photo

Congratulations to Ajar Kochar Brian Bergmark and the entire Brigham and Women’s team on their first cases with the HyperVue Imaging System! We look forward to bringing DeepOCT+NIRS to more patients, physicians, and cath labs! Kevin Croce MD, PhD David Gross Zaid Almarzooq

Congratulations to <a href="/Ajar_Kochar/">Ajar Kochar</a> <a href="/BrianBergmark/">Brian Bergmark</a> and the entire Brigham and Women’s team on their first cases with the HyperVue Imaging System! We look forward to bringing DeepOCT+NIRS to more patients, physicians, and cath labs!

<a href="/kevinjamescroce/">Kevin Croce MD, PhD</a> <a href="/DaveGrossMDPhD/">David Gross</a> <a href="/ZaidAlMarzooq/">Zaid Almarzooq</a>
Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

What the SpectraWAVE team accomplishes is truly amazing. HyperVue had already set a new bar for intravascular imaging, and this follow-on FDA clearance continues to forge a clear path forward to help interventionalists optimize stenting and outcomes for their patients

SpectraWAVE (@spectrawave_med) 's Twitter Profile Photo

It’s time for #TCT2023! Come by Booth 2237 to learn more about the future of intravascular imaging with the HyperVue Imaging System! #ImageWithoutCompromise #DeepOCT

It’s time for #TCT2023! Come by Booth 2237 to learn more about the future of intravascular imaging with the HyperVue Imaging System! #ImageWithoutCompromise #DeepOCT
SpectraWAVE (@spectrawave_med) 's Twitter Profile Photo

Join Ziad Ali for a presentation on the HyperVue Imaging System tomorrow 10/26 at #TCT2023 to learn more about SpectraWAVE’s next generation intravascular imaging platform! #DeepOCT

Join <a href="/ziadalinyc/">Ziad Ali</a> for a presentation on the HyperVue Imaging System tomorrow 10/26 at #TCT2023 to learn more about SpectraWAVE’s next generation intravascular imaging platform! #DeepOCT
Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

Pretty alarming that a company whose core competency is supply chain optimization can’t navigate the complexities of US healthcare reimbursement to make a profitable business. I know it takes subject matter expertise, but our system often feels unnecessarily complex…

Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

The good thing about airlines no longer serving meals on long flights is it becomes socially acceptable to eat ridiculous amount of snacks for dinner. It’s not healthy, but it’s sneaky enjoyable. I’ve never understood my toddlers eating habits better than I do now.

Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

This is a big deal for patients! A 22 study, ~16,000 patient meta-analysis showed significant improvements in patient outcomes with intravascular imaging guided PCI. Congrats to all the imaging study authors and the #ESCCongress guideline task force!

Jason Tucker-Schwartz, PhD (@jtuckerschwartz) 's Twitter Profile Photo

Someone recently asked about my most proud accomplishment in 4.5 years at SpectraWAVE. I couldn't answer - too many to count. One that is certainly at the top of the list though is working closely with our mgmt team to pull together this amazing syndicate and raise. Let's GO!